Steven R Hwang

16PUBLICATIONS
100CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 23, 2026
Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T-Cell Lymphoma: A Real-World National Cancer Database Study.

|Apr 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Dec 11, 2025
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

|Feb 18, 2025
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience.

Steven R Hwang, Richard C Godby, Brianna J Negaard

|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Rahul S Bhansali, Fredrik Ellin, Thomas Relander

|Jan 11, 2024
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy.

Jessica F Burlile, Kelsey M Frechette, William G Breen

Pageof 3

Frequent Collaborators

7 joint publications

Yucai Wang

5 joint publications

Matthew J Maurer

5 joint publications

N Nora Bennani

4 joint publications

Stephen M Ansell